Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changho Lee

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Journal of Ginseng Research|January 13, 2021
Ginsenoside 20(S)-protopanaxadiol induces cell death in human endometrial cancer cells via apoptosisHantae Jo, Dongmin Jang, Sun Kyu Park, et al.
Experimental & Molecular Medicine|February 13, 2023
ANGPTL4 stabilizes atherosclerotic plaques and modulates the phenotypic transition of vascular smooth muscle cells through KLF4 downregulationDong Im Cho, Min Joo Ahn, Hyang Hee Cho, et al.
Cancer Immunology, Immunotherapy : CII|May 21, 2026
Overcoming resistance in CD44-overexpressing myeloma through combination therapy with ATRA, bortezomib, and NK cellsVan-Tan Nguyen, Thuy Nguyen Thi, Van-Dinh-Huan Tran, et al.
Science Advances|March 26, 2019
Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's diseaseJong-Hyun Park, Yeon Ha Ju, Ji Won Choi, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Journal of Ginseng Research|January 13, 2021
Ginsenoside 20(S)-protopanaxadiol induces cell death in human endometrial cancer cells via apoptosisHantae Jo, Dongmin Jang, Sun Kyu Park, et al.
Experimental & Molecular Medicine|February 13, 2023
ANGPTL4 stabilizes atherosclerotic plaques and modulates the phenotypic transition of vascular smooth muscle cells through KLF4 downregulationDong Im Cho, Min Joo Ahn, Hyang Hee Cho, et al.
Cancer Immunology, Immunotherapy : CII|May 21, 2026
Overcoming resistance in CD44-overexpressing myeloma through combination therapy with ATRA, bortezomib, and NK cellsVan-Tan Nguyen, Thuy Nguyen Thi, Van-Dinh-Huan Tran, et al.
Science Advances|March 26, 2019
Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's diseaseJong-Hyun Park, Yeon Ha Ju, Ji Won Choi, et al.
Pageof 12